Lonza (LONN)

Sector:

Medicine and Biotech Research

Index:

Swiss Leader Index

Sf 73.85
   
  • 52 Week High: Sf74.00
  • 52 Week Low: Sf32.81
  • Currency: Swiss Francs
  • Shares Issued: 52.81m
  • Market Cap: Sf3,899.84m

Lonza Overview

Lonza Group is a Swiss chemicals and biotechnology company. The group provides a number of products and services to the pharmaceutical and life science industries.

3 Month Chart (17-05-2013)

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 2.9%
Div Cover 1.4
Op Mrgn 9.7%
ROCE 5.5%
Latest F'cast
P/E 24.8
PEG n/a
Pr/Revenue 1.4
Pr/Book 1.7
Latest F'cast
Revenue 0.4%
PBT -47.0%
EPS -46.3%
DPS n/a

Lonza Fundamentals

Year Ending Revenue (Sfm) Pre-tax (Sfm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 2,870.00 361.00 6.33Sf n/a n/a +35% 1.75 0.0%
31-Dec-08 2,937.00 475.00 8.81Sf 11.1 0.3 +39% 1.75 1.8%
31-Dec-09 2,690.00 186.00 3.19Sf 22.9 n/a -64% 1.75 2.4%
31-Dec-10 2,680.00 330.00 5.55Sf 13.5 0.2 +74% 2.15 2.9%
31-Dec-11 2,692.00 175.00 2.98Sf 18.6 n/a -46% 2.15 3.9%

Lonza Forecasts

Year Ending Revenue (Sfm) Pre-tax (Sfm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 3,925.00 236.79 4.39Sf 16.8 0.0 +14,634% 2.16Sf 3.0%
31-Dec-13 3,919.71 278.62 4.59Sf 16.1 3.6 +4% 2.12Sf 2.9%
31-Dec-14 4,125.74 342.48 5.42Sf 13.6 0.8 +18% 2.38Sf 3.3%

Copyright © 2013 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Lonza Market Data

Currency Swiss Francs
% Change 0.07 %
52 Week High Sf74.00
52 Week Low Sf32.81
Shares Issued 52.81m
Market Cap Sf3,899.84m

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 10
Sell 1
Strong Sell 0
Total 13
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page